Rhythm Pharmaceuticals Inc. (RYTM) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear

Rhythm Pharmaceuticals In...

NASDAQ: RYTM · Real-Time Price · USD
99.02
1.79 (1.84%)
At close: Oct 03, 2025, 3:59 PM

Rhythm Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-13.1 -14.36 -8.38 -7.11
PEG Ratio
-0.42 1.63 -0.05 0.13
PS Ratio
26.24 34.24 64.21 156.95
PB Ratio
20.75 15.62 5.74 1.74
P/FCF Ratio
-29.98 -19.47 -8.54 -3.27
P/OCF Ratio
-29.98 -19.47 -8.75 -3.39
OCF/S Ratio
-0.88 -1.76 -7.34 -46.29
Debt / Equity Ratio
0.02 0.01 0.01 0.01
Quick Ratio
3.08 5.43 8.83 7.10
Current Ratio
3.24 5.58 8.90 7.10
Asset Turnover
0.33 0.23 0.06 0.01
Interest Coverage
-12.89 -13.27 -34.45 n/a
Return on Equity
-1.58 -1.09 -0.69 -0.24
Return on Assets
-0.66 -0.56 -0.47 -0.21
Return on Invested Capital
-0.96 -0.66 -0.52 -0.59
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.90 0.88 0.91 0.81
Net Profit Margin
-2 -2.39 -7.66 -22.07
Pretax Profit Margin
-2 -2.38 -7.66 -22.07
Operating Profit Margin
-2.04 -2.38 -7.58 -53.92
FCF Margin
-0.88 -1.76 -7.52 -48.01
EBITDA Margin
-1.83 -2.18 -7.37 -21.7